hGH to drive novel drug delivery market
A surge in research into novel drug delivery systems will occur as companies seek to differentiate their products in response to pressure from biosimilars, according to a publication from Frost & Sullivan.
Archives for September 16, 2008
Small step for MannKind resurrects inhaled insulin
MannKind’s inhaled insulin treatment, Technosphere, has met its study goal in the first of three Phase III trials, leading to Pfizer transferring its remaining Exubera patients to the treatment.
Formatech’s solution for improved solubility
Formatech hopes its new formulation method, which solubilises compounds in micelles consisting of fatty acids or alcohols, will improve both the safety and bioavailability of pharmaceutical products.
Pharma outsourcing: people on the move
Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.
FDA blocks imports from two Ranbaxy plants
The FDA has issued generics giant Ranbaxy Laboratories with two warning letters, detailing “extensive deviations from US cGMP requirements” at the firm’s manufacturing plants in Dewas and Paonta Sahib, India.
Charles River expands Discovery Services
Charles River Laboratories has agreed to buy US-based drug discovery imaging expert Molecular Imaging Research, Inc. (MIR) for approximately $12.5m (€8.8m) in cash.